BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasten KR, Prakash PS, Unsinger J, Goetzman HS, England LG, Cave CM, Seitz AP, Mazuski CN, Zhou TT, Morre M, Hotchkiss RS, Hildeman DA, Caldwell CC. Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through gamma delta T-cell IL-17 production in a murine model of sepsis. Infect Immun 2010;78:4714-22. [PMID: 20823197 DOI: 10.1128/IAI.00456-10] [Cited by in Crossref: 81] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Ge Y, Huang M, Yao YM. Biology of Interleukin-17 and Its Pathophysiological Significance in Sepsis. Front Immunol 2020;11:1558. [PMID: 32849528 DOI: 10.3389/fimmu.2020.01558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Thampy LK, Remy KE, Walton AH, Hong Z, Liu K, Liu R, Yi V, Burnham CD, Hotchkiss RS. Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration. PLoS One 2018;13:e0199497. [PMID: 29944697 DOI: 10.1371/journal.pone.0199497] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
3 Peters van Ton AM, Kox M, Abdo WF, Pickkers P. Precision Immunotherapy for Sepsis. Front Immunol 2018;9:1926. [PMID: 30233566 DOI: 10.3389/fimmu.2018.01926] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 13.5] [Reference Citation Analysis]
4 Patil NK, Bohannon JK, Sherwood ER. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Pharmacol Res 2016;111:688-702. [PMID: 27468649 DOI: 10.1016/j.phrs.2016.07.019] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 11.2] [Reference Citation Analysis]
5 Chen W, Lai D, Li Y, Wang X, Pan Y, Fang X, Fan J, Shu Q. Neuronal-Activated ILC2s Promote IL-17A Production in Lung γδ T Cells During Sepsis. Front Immunol 2021;12:670676. [PMID: 33995408 DOI: 10.3389/fimmu.2021.670676] [Reference Citation Analysis]
6 Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Weigel C, Bauer M, Griffith TS, Förster M, Brunkhorst FM, Badovinac VP, Rubio I. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function. PLoS One 2014;9:e115094. [PMID: 25541945 DOI: 10.1371/journal.pone.0115094] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
7 Simmons J, Pittet JF. The coagulopathy of acute sepsis. Curr Opin Anaesthesiol. 2015;28:227-236. [PMID: 25590467 DOI: 10.1097/aco.0000000000000163] [Cited by in Crossref: 113] [Cited by in F6Publishing: 68] [Article Influence: 16.1] [Reference Citation Analysis]
8 de Pablo R, Monserrat J, Prieto A, Alvarez-Mon M. Role of circulating lymphocytes in patients with sepsis. Biomed Res Int 2014;2014:671087. [PMID: 25302303 DOI: 10.1155/2014/671087] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
9 Rani M, Zhang Q, Schwacha MG. Burn wound γδ T-cells support a Th2 and Th17 immune response. J Burn Care Res 2014;35:46-53. [PMID: 24270084 DOI: 10.1097/01.bcr.0000440705.91099.cc] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
10 Costa MF, de Negreiros CB, Bornstein VU, Valente RH, Mengel J, Henriques Md, Benjamim CF, Penido C. Murine IL-17+ Vγ4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis. BMC Immunol 2015;16:36. [PMID: 26037291 DOI: 10.1186/s12865-015-0098-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
11 Shindo Y, Unsinger J, Burnham CA, Green JM, Hotchkiss RS. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock 2015;43:334-43. [PMID: 25565644 DOI: 10.1097/SHK.0000000000000317] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
12 Horiguchi H, Loftus TJ, Hawkins RB, Raymond SL, Stortz JA, Hollen MK, Weiss BP, Miller ES, Bihorac A, Larson SD, Mohr AM, Brakenridge SC, Tsujimoto H, Ueno H, Moore FA, Moldawer LL, Efron PA; Sepsis and Critical Illness Research Center Investigators. Innate Immunity in the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome and Its Implications for Therapy.Front Immunol. 2018;9:595. [PMID: 29670613 DOI: 10.3389/fimmu.2018.00595] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 16.0] [Reference Citation Analysis]
13 Aziz M, Jacob A, Yang WL, Matsuda A, Wang P. Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013;93:329-42. [PMID: 23136259 DOI: 10.1189/jlb.0912437] [Cited by in Crossref: 177] [Cited by in F6Publishing: 165] [Article Influence: 17.7] [Reference Citation Analysis]
14 Chousterman BG, Arnaud M. Is There a Role for Hematopoietic Growth Factors During Sepsis? Front Immunol 2018;9:1015. [PMID: 29977234 DOI: 10.3389/fimmu.2018.01015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
15 Anantha RV, Mazzuca DM, Xu SX, Porcelli SA, Fraser DD, Martin CM, Welch I, Mele T, Haeryfar SM, McCormick JK. T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis. Clin Exp Immunol 2014;178:292-309. [PMID: 24965554 DOI: 10.1111/cei.12404] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
16 van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol 2017;17:407-20. [PMID: 28436424 DOI: 10.1038/nri.2017.36] [Cited by in Crossref: 524] [Cited by in F6Publishing: 495] [Article Influence: 104.8] [Reference Citation Analysis]
17 Shindo Y, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CD, Green JM, Morre M, Bochicchio GV, Hotchkiss RS. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia. J Leukoc Biol 2017;101:543-54. [PMID: 27630218 DOI: 10.1189/jlb.4A1215-581R] [Cited by in Crossref: 53] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
18 Li Y, Wei C, Xu H, Jia J, Wei Z, Guo R, Jia Y, Wu Y, Li Y, Qi X, Li Z, Gao X. The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection. Mediators Inflamm 2018;2018:6587296. [PMID: 29743811 DOI: 10.1155/2018/6587296] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
19 Ghuman H, Voelz K. Innate and Adaptive Immunity to Mucorales. J Fungi (Basel) 2017;3:E48. [PMID: 29371565 DOI: 10.3390/jof3030048] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
20 Spec A, Shindo Y, Burnham CA, Wilson S, Ablordeppey EA, Beiter ER, Chang K, Drewry AM, Hotchkiss RS. T cells from patients with Candida sepsis display a suppressive immunophenotype. Crit Care 2016;20:15. [PMID: 26786705 DOI: 10.1186/s13054-016-1182-z] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 9.2] [Reference Citation Analysis]
21 Ward PA, Bosmann M. A historical perspective on sepsis. Am J Pathol 2012;181:2-7. [PMID: 22642906 DOI: 10.1016/j.ajpath.2012.05.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
22 Niu R, Gao H, Zhou Y, Zhang J. Ouabain Attenuates Sepsis-Induced Immunosuppression in Mice by Activation and Anti-Apoptosis of T Cells. Med Sci Monit 2018;24:2720-7. [PMID: 29717720 DOI: 10.12659/MSM.906889] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Okeke EB, Uzonna JE. In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine. J Innate Immun 2016;8:156-70. [PMID: 26771196 DOI: 10.1159/000442469] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
24 Beckmann N, Salyer CE, Crisologo PA, Nomellini V, Caldwell CC. Staging and Personalized Intervention for Infection and Sepsis. Surg Infect (Larchmt) 2020;21:732-44. [PMID: 32240042 DOI: 10.1089/sur.2019.363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Venet F, Lepape A, Monneret G. Clinical review: flow cytometry perspectives in the ICU - from diagnosis of infection to monitoring of injury-induced immune dysfunctions. Crit Care 2011;15:231. [PMID: 22017882 DOI: 10.1186/cc10333] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 5.9] [Reference Citation Analysis]
26 Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy.Nat Rev Immunol. 2013;13:862-874. [PMID: 24232462 DOI: 10.1038/nri3552] [Cited by in Crossref: 1107] [Cited by in F6Publishing: 1062] [Article Influence: 123.0] [Reference Citation Analysis]
27 Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent JL. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2:16045. [PMID: 28117397 DOI: 10.1038/nrdp.2016.45] [Cited by in Crossref: 420] [Cited by in F6Publishing: 393] [Article Influence: 70.0] [Reference Citation Analysis]
28 Xia Q, Zhou Y, Wang X, Fu S. Interleukin-1 receptor-associated kinase 3 downregulation in peripheral blood mononuclear cells attenuates immunosuppression in sepsis. Exp Ther Med 2018;15:1586-93. [PMID: 29434744 DOI: 10.3892/etm.2017.5549] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
29 Bai H, Gao X, Zhao L, Peng Y, Yang J, Qiao S, Zhao H, Wang S, Fan Y, Joyee AG, Yao Z, Yang X. Respective IL-17A production by γδ T and Th17 cells and its implication in host defense against chlamydial lung infection. Cell Mol Immunol 2017;14:850-61. [PMID: 27796286 DOI: 10.1038/cmi.2016.53] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
30 Wong HR. Clinical review: sepsis and septic shock--the potential of gene arrays. Crit Care 2012;16:204. [PMID: 22316118 DOI: 10.1186/cc10537] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]
31 Leelahavanichkul A, Somparn P, Bootprapan T, Tu H, Tangtanatakul P, Nuengjumnong R, Worasilchai N, Tiranathanagul K, Eiam-ong S, Levine M, Chinampon A, Srisawat N. High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse. Am J Physiol Regul Integr Comp Physiol 2015;309:R223-34. [PMID: 25994956 DOI: 10.1152/ajpregu.00238.2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
32 Hotchkiss RS, Crouser E. Imaging Apoptosis in Sepsis--A Technology We Would Die for! Crit Care Med 2015;43:2506-8. [PMID: 26468702 DOI: 10.1097/CCM.0000000000001289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
33 Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, Patera AC, Blair W, Krishnan S, Hotchkiss R. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 2014;18:R3. [PMID: 24387680 DOI: 10.1186/cc13176] [Cited by in Crossref: 157] [Cited by in F6Publishing: 152] [Article Influence: 19.6] [Reference Citation Analysis]
34 Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, Monteiro ML, dos Reis MA, Corrêa RR, Celes MR. Neonatal sepsis and inflammatory mediators. Mediators Inflamm 2014;2014:269681. [PMID: 25614712 DOI: 10.1155/2014/269681] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
35 Davies R, O'Dea K, Gordon A. Immune therapy in sepsis: Are we ready to try again? J Intensive Care Soc 2018;19:326-44. [PMID: 30515242 DOI: 10.1177/1751143718765407] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
36 Sesti-Costa R, Borges MD, Lanaro C, de Albuquerque DM, Saad STO, Costa FF. Inflammatory Dendritic Cells Contribute to Regulate the Immune Response in Sickle Cell Disease. Front Immunol 2020;11:617962. [PMID: 33613546 DOI: 10.3389/fimmu.2020.617962] [Reference Citation Analysis]
37 Demaret J, Villars-Méchin A, Lepape A, Plassais J, Vallin H, Malcus C, Poitevin-Later F, Monneret G, Venet F. Elevated plasmatic level of soluble IL-7 receptor is associated with increased mortality in septic shock patients. Intensive Care Med 2014;40:1089-96. [PMID: 24962718 DOI: 10.1007/s00134-014-3346-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
38 Schlosser K, Taha M, Deng Y, McIntyre LA, Mei SHJ, Stewart DJ. High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice. Thorax 2018;73:248-61. [PMID: 28947667 DOI: 10.1136/thoraxjnl-2017-210413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
39 Sasaki JR, Zhang Q, Schwacha MG. Burn induces a Th-17 inflammatory response at the injury site. Burns 2011;37:646-51. [PMID: 21353393 DOI: 10.1016/j.burns.2011.01.028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
40 Johnson BL 3rd, Rice TC, Xia BT, Boone KI, Green EA, Gulbins E, Caldwell CC. Amitriptyline Usage Exacerbates the Immune Suppression Following Burn Injury. Shock 2016;46:541-8. [PMID: 27172154 DOI: 10.1097/SHK.0000000000000648] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
41 Alam MS, Getz M, Safeukui I, Yi S, Tamez P, Shin J, Velázquez P, Haldar K. Genomic expression analyses reveal lysosomal, innate immunity proteins, as disease correlates in murine models of a lysosomal storage disorder. PLoS One 2012;7:e48273. [PMID: 23094108 DOI: 10.1371/journal.pone.0048273] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
42 Poiret T, Rane L, Remberger M, Omazic B, Gustafsson-Jernberg A, Vudattu NK, Ahmed R, Ernberg I, Winiarski J, Magalhaes I, Ringden O, Maeurer M. Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults. BMC Immunol 2014;15:25. [PMID: 24946690 DOI: 10.1186/1471-2172-15-25] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
43 Li J, Kong P, Chen C, Tang J, Jin X, Yan J, Wang Y. Targeting IL-17A Improves the Dysmotility of the Small Intestine and Alleviates the Injury of the Interstitial Cells of Cajal during Sepsis. Oxid Med Cell Longev 2019;2019:1475729. [PMID: 31531179 DOI: 10.1155/2019/1475729] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmelé T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight 2018;3:98960. [PMID: 29515037 DOI: 10.1172/jci.insight.98960] [Cited by in Crossref: 126] [Cited by in F6Publishing: 125] [Article Influence: 31.5] [Reference Citation Analysis]
45 Shin J, Jin M. Potential Immunotherapeutics for Immunosuppression in Sepsis. Biomol Ther (Seoul) 2017;25:569-77. [PMID: 29081088 DOI: 10.4062/biomolther.2017.193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
46 Busani S, Roat E, Serafini G, Mantovani E, Biagioni E, Girardis M. The Role of Adjunctive Therapies in Septic Shock by Gram Negative MDR/XDR Infections. Can J Infect Dis Med Microbiol 2017;2017:2808203. [PMID: 28775744 DOI: 10.1155/2017/2808203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
47 Bergmann CB, Salyer CE, Beckmann N, Caldwell CC. Intraperitoneal Neutrophil IL-10 production is promoted by interferon γ in a murine model of sepsis model in the acute phase of sepsis. Biochem Biophys Res Commun 2020;530:278-84. [PMID: 32828299 DOI: 10.1016/j.bbrc.2020.07.089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Boomer JS, Green JM, Hotchkiss RS. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer? Virulence 2014;5:45-56. [PMID: 24067565 DOI: 10.4161/viru.26516] [Cited by in Crossref: 161] [Cited by in F6Publishing: 145] [Article Influence: 17.9] [Reference Citation Analysis]
49 Unsinger J, Burnham CA, McDonough J, Morre M, Prakash PS, Caldwell CC, Dunne WM Jr, Hotchkiss RS. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2-hit model of fungal sepsis. J Infect Dis 2012;206:606-16. [PMID: 22693226 DOI: 10.1093/infdis/jis383] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 8.0] [Reference Citation Analysis]
50 Piliponsky AM, Shubin NJ, Lahiri AK, Truong P, Clauson M, Niino K, Tsuha AL, Nedospasov SA, Karasuyama H, Reber LL, Tsai M, Mukai K, Galli SJ. Basophil-derived tumor necrosis factor can enhance survival in a sepsis model in mice. Nat Immunol 2019;20:129-40. [PMID: 30664762 DOI: 10.1038/s41590-018-0288-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
51 Mackall CL, Fry TJ, Gress RE. Harnessing the biology of IL-7 for therapeutic application. Nat Rev Immunol 2011;11:330-42. [PMID: 21508983 DOI: 10.1038/nri2970] [Cited by in Crossref: 344] [Cited by in F6Publishing: 325] [Article Influence: 31.3] [Reference Citation Analysis]
52 Piliponsky AM, Lahiri A, Truong P, Clauson M, Shubin NJ, Han H, Ziegler SF. Thymic Stromal Lymphopoietin Improves Survival and Reduces Inflammation in Sepsis. Am J Respir Cell Mol Biol 2016;55:264-74. [PMID: 26934097 DOI: 10.1165/rcmb.2015-0380OC] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
53 Pugh AM, Auteri NJ, Goetzman HS, Caldwell CC, Nomellini V. A Murine Model of Persistent Inflammation, Immune Suppression, and Catabolism Syndrome. Int J Mol Sci 2017;18:E1741. [PMID: 28796194 DOI: 10.3390/ijms18081741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
54 Chen D, Tang TX, Deng H, Yang XP, Tang ZH. Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation, Survival, and Homeostasis. Front Immunol 2021;12:747324. [PMID: 34925323 DOI: 10.3389/fimmu.2021.747324] [Reference Citation Analysis]
55 Herzig DS, Driver BR, Fang G, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med 2012;185:291-300. [PMID: 22135342 DOI: 10.1164/rccm.201108-1560OC] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
56 Li KP, Shanmuganad S, Carroll K, Katz JD, Jordan MB, Hildeman DA. Dying to protect: cell death and the control of T-cell homeostasis. Immunol Rev 2017;277:21-43. [PMID: 28462527 DOI: 10.1111/imr.12538] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
57 Hou L, Jie Z, Desai M, Liang Y, Soong L, Wang T, Sun J. Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis. J Immunol. 2013;190:621-629. [PMID: 23233727 DOI: 10.4049/jimmunol.1201970] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
58 Fenner BP, Darden DB, Kelly LS, Rincon J, Brakenridge SC, Larson SD, Moore FA, Efron PA, Moldawer LL. Immunological Endotyping of Chronic Critical Illness After Severe Sepsis. Front Med (Lausanne) 2020;7:616694. [PMID: 33659259 DOI: 10.3389/fmed.2020.616694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
59 Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260-268. [PMID: 23427891 DOI: 10.1016/s1473-3099(13)70001-x] [Cited by in Crossref: 779] [Cited by in F6Publishing: 499] [Article Influence: 86.6] [Reference Citation Analysis]